Omada Health (NASDAQ:OMDA) CAO Sells $39,597.83 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 2,083 shares of the firm’s stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $19.01, for a total transaction of $39,597.83. Following the completion of the sale, the chief accounting officer owned 5,025 shares of the company’s stock, valued at $95,525.25. This trade represents a 29.31% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Craig Gracey also recently made the following trade(s):

• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total value of $37,494.00.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The stock was sold at an average price of $17.42, for a total value of $120,093.48.

Omada Health Price Performance

Omada Health stock opened at $20.89 on Monday. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92. The firm’s 50-day simple moving average is $16.51 and its 200 day simple moving average is $14.84. The firm has a market capitalization of $1.24 billion and a PE ratio of -77.37.

Omada Health (NASDAQ:OMDA) last posted its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.03. The firm had revenue of $78.05 million during the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. On average, research analysts expect that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

OMDA has been the topic of a number of research analyst reports. Barclays lifted their target price on Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a report on Friday, May 8th. Citizens Jmp raised their price objective on Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a report on Friday, May 8th. BMO Capital Markets reduced their price objective on Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a research note on Friday, March 6th. Evercore reiterated an “outperform” rating and set a $20.00 target price on shares of Omada Health in a report on Friday, May 8th. Finally, Needham & Company LLC reissued a “buy” rating and set a $28.00 target price on shares of Omada Health in a research report on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $22.91.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Perceptive Advisors LLC acquired a new stake in shares of Omada Health during the second quarter worth $44,402,000. Millennium Management LLC boosted its holdings in shares of Omada Health by 1,195.0% in the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock valued at $35,855,000 after buying an additional 2,096,705 shares during the period. Divisadero Street Capital Management LP acquired a new position in shares of Omada Health in the 3rd quarter valued at about $30,510,000. Jefferies Financial Group Inc. bought a new stake in shares of Omada Health during the 4th quarter valued at about $16,948,000. Finally, SG Americas Securities LLC acquired a new stake in Omada Health during the first quarter worth about $10,401,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.